| License: Creative Commons Attribution 4.0 (1MB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-351959
- DOI to cite this document:
- 10.5283/epub.35195
Abstract
The etiology of Langerhans cell histiocytosis (LCH), a mix between immune dysregulation, inflammation, and malignancy, remains unclear.1; 2; 3 ; 4 In half of the patients, an oncogenic BRAF mutation is found. 3 Because of the diversity of symptoms, the diagnosis of LCH, as defined by the Histiocyte Society, is often made with considerable delay. Multisystemic LCH, affecting 2 or more organ ...
Owner only: item control page